Zorelbin 50 MG Injection 5 ML

Zorelbin 50 MG Injection 5 ML is used for the following:

• Treatment of advanced breast cancer

• Management of metastatic breast cancer

• Therapy for non-small cell lung cancer (NSCLC)

• Treatment of advanced NSCLC

• Controlling cancer when other treatments have failed

• Management of cancer-related symptoms

• Combination therapy with other cancer medicines

• Improving quality of life in advanced cancer patients

• Extending survival in specific cancer types

• Alternative treatment when standard therapy isn't tolerated

Follow these instructions when Zorelbin 50 MG Injection 5 ML is administered:

• This injection must only be given by qualified healthcare professionals in clinical settings.

• The injection is administered exclusively through intravenous infusion.

• Proper venous access must be established before administration.

• The injection site should be monitored throughout the procedure.

• After administration, the injection site should be checked for any reactions.

• Regular follow-up appointments are necessary to monitor your response.

• Your doctor will determine the appropriate schedule for your treatment.

Zorelbin 50 MG Injection 5 ML is administered intravenously.

Zorelbin 50 MG Injection 5 ML contains vinorelbine (50 mg/5 ml), which works on the body as follows:

• Anti-mitotic action: Vinorelbine prevents cancer cells from dividing by interfering with structures called microtubules, which are essential for cell division.

• Tubulin binding: It attaches to proteins called tubulins in cancer cells, preventing them from forming the mitotic spindle needed for chromosomes to separate during cell division.

• Selective targeting: The medicine primarily affects rapidly dividing cells like cancer cells, while having less impact on most normal tissues that divide more slowly.

• Induction of cell death: By disrupting the completion of cell division, vinorelbine causes cancer cells to undergo programmed cell death, known as apoptosis.

• Store Zorelbin 50 MG Injection 5 ML in a refrigerator at 2-8°C.

• Keep the vial in its original packaging to protect from light.

• Do not freeze the medicine.

• Store all medicines out of reach of children.

• Check the expiry date before use and never use Zorelbin 50 MG Injection 5 ML after this date.

• Dispose of unused portions following proper biohazard guidelines.

• During cancer treatment with Zorelbin 50 MG Injection 5 ML, maintain adequate protein and calorie intake through small, frequent meals to help combat fatigue and support your immune system.

• Maintain strict hand hygiene and avoid crowded places during periods of low white blood cell counts to minimise infection risk.